|
DCK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.098000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.720590E-01 |
| Normal-vs-Stage2 |
7.002400E-01 |
| Normal-vs-Stage3 |
7.356000E-01 |
| Normal-vs-Stage4 |
5.501400E-01 |
| Stage1-vs-Stage2 |
1.119230E-01 |
| Stage1-vs-Stage3 |
3.404000E-01 |
| Stage1-vs-Stage4 |
1.291640E-01 |
| Stage2-vs-Stage3 |
4.789800E-01 |
| Stage2-vs-Stage4 |
7.649800E-01 |
| Stage3-vs-Stage4 |
4.031600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.289600E-01 |
| Normal-vs-AfricanAmerican |
6.307800E-01 |
| Normal-vs-Asian |
7.466800E-01 |
| Caucasian-vs-AfricanAmerican |
7.246800E-01 |
| Caucasian-vs-Asian |
9.657600E-01 |
| AfricanAmerican-vs-Asian |
9.354000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.563600E-01 |
| Normal-vs-Female |
5.665800E-01 |
| Male-vs-Female |
1.169600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.082400E-01 |
| Normal-vs-Extreme_Weight |
1.341610E-01 |
| Normal-vs-Obese |
8.501200E-01 |
| Normal-vs-Extreme_Obese |
1.931230E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.627400E-01 |
| Normal_Weight-vs-Obese |
4.108400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.978600E-01 |
| Extreme_Weight-vs-Obese |
9.395800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.672600E-01 |
| Obese-vs-Extreme_Obese |
1.977990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.621800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.398600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.464600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.126600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.116200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.579600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.116400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.545600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.954810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.668600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.099800E-01 |
| Normal-VS-Type2 PRCC |
6.286200E-01 |
| Normal-VS-KIRP CIMP |
8.603400E-01 |
| Normal-VS-Unclassified PRCC |
4.818000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.543200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.646000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.509900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.890200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.945250E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.311800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.447600E-02 |
| Normal-vs-N1 |
7.349600E-01 |
| Normal-vs-N2 |
4.094400E-01 |
| N0-vs-N1 |
6.624200E-02 |
| N0-vs-N2 |
8.724400E-01 |
| N1-vs-N2 |
3.857200E-01 |
|
|
